Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by toinv261on Mar 19, 2015 2:44pm
131 Views
Post# 23539839

Ignore List

Ignore ListI've been experimenting with the ignore list and it works beautifully. You just go under the alias' name and click user actions and a drop down list comes up and one of the options is ignore user.

It works beautifully and makes it much more easy to concentrate on the intelligent posts and those who provide a proper, thoughtful discourse. It sure makes it more productive.

If I want to look at all posters I just go into RVX at Stockhouse and check the posts without signing in.

I was becoming a bit concerned recently that some of the posts recently might impact intelligent potential investors but on second thought I really think that no intelligent investor would read more than 3 of those posts before he/she just ignors them or uses the ignore function.

The post by bylosellhi on Mar 18th at 1:42 gave a clear explanation of trolls so check it out. He/she said ignore the trolls. Do not respond to their postings.

Also check the Leeuwenhoek at https://www.resverlogix.com/upload/media_element/208/01/leeuwenhoeck-research-initiation-report-rvx-march-16-2015.pdfI urge everyone to read the report. Their estimate of BETonMACE at this stage (pre trial design announcement is 54%).

I try my best to be objective and present facts and POVs as clear and objectively as I can. Whether I achieve this is another question. I'm not to bright but I can add to the dialogue regarding communications and statistical analysis.

Anyone who reads my posts knows that I have a positive bias. I've taken many shots at RVX and lost
a lot of money on paper but I believe in the science so I continue to buy. And as every day and post by our science people goes by I become a stronger believer.

I urge everyone to keep the level of discourse high. It doesn't matter to me whether you are pro or con RVX because I want to learn from intelligent thinking. Just bring as much objectivity, knowledge and experience to our collective knowledge bank for everyone benefit because, either way, we will all benefit!!!

GLTA DYODD
I'm feeling really hopeful.
Cheers
Toinv :)

Bullboard Posts